Intellia Therapeutics (Q54621387)
Jump to navigation
Jump to search
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.
Language | Label | Description | Also known as |
---|---|---|---|
English | Intellia Therapeutics |
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system. |
Statements
2014
1 reference
15 November 2018
Identifiers
1 reference
10 September 2022
1 reference
Intellia Therapeutics (United States)
6 July 2021
4,181
31 July 2014
21 April 2020
0 references
Sitelinks
Wikipedia(3 entries)
- dewiki Intellia Therapeutics
- enwiki Intellia Therapeutics
- fawiki اینتلی تراپیوتیکس